ÂÜÀòÂÒÂ×

Dawn Culp is a regulatory affairs expert with extensive experience in the pharmaceutical industry. Currently serving as Vice President of Regulatory Affairs at Hikma Pharmaceuticals since August 2020, Dawn previously held various leadership roles at Mylan, including Vice President of Global Regulatory Affairs Policy and Senior Director of Regulatory Affairs, from September 2003 to August 2020. Dawn's career also includes significant positions at Apotex Inc. as Director of Regulatory Affairs and at Novopharm as Manager of Provincial Submissions. Dawn holds a Bachelor of Science degree in Pharmacology from the University of Toronto, obtained between 1982 and 1987.